ZA200500768B - Crystal forms os quinoxaline-2-carboxylic acid Ä4-carbomoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-,ethyl-octylÜ-amide - Google Patents
Crystal forms os quinoxaline-2-carboxylic acid Ä4-carbomoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-,ethyl-octylÜ-amideInfo
- Publication number
- ZA200500768B ZA200500768B ZA200500768A ZA200500768A ZA200500768B ZA 200500768 B ZA200500768 B ZA 200500768B ZA 200500768 A ZA200500768 A ZA 200500768A ZA 200500768 A ZA200500768 A ZA 200500768A ZA 200500768 B ZA200500768 B ZA 200500768B
- Authority
- ZA
- South Africa
- Prior art keywords
- octylü
- carbomoyl
- fluorobenzyl
- quinoxaline
- dihydroxy
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 1
- UPUZGXILYFKSGE-UHFFFAOYSA-N quinoxaline-2-carboxylic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CN=C21 UPUZGXILYFKSGE-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40321602P | 2002-08-12 | 2002-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200500768B true ZA200500768B (en) | 2006-07-26 |
Family
ID=31715961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200500768A ZA200500768B (en) | 2002-08-12 | 2005-01-26 | Crystal forms os quinoxaline-2-carboxylic acid Ä4-carbomoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-,ethyl-octylÜ-amide |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20040072834A1 (is) |
| EP (1) | EP1539715A1 (is) |
| JP (1) | JP2005538130A (is) |
| AP (1) | AP2005003226A0 (is) |
| AR (1) | AR040839A1 (is) |
| AU (1) | AU2003250450A1 (is) |
| BR (1) | BR0313378A (is) |
| CA (1) | CA2494776A1 (is) |
| EC (1) | ECSP055588A (is) |
| GT (1) | GT200300169A (is) |
| IL (1) | IL166548A0 (is) |
| IS (1) | IS7674A (is) |
| MX (1) | MXPA05001781A (is) |
| NO (1) | NO20050540L (is) |
| OA (1) | OA12894A (is) |
| PA (1) | PA8580401A1 (is) |
| PE (1) | PE20040866A1 (is) |
| TN (1) | TNSN05035A1 (is) |
| TW (1) | TW200407316A (is) |
| UY (1) | UY27928A1 (is) |
| WO (1) | WO2004014875A1 (is) |
| ZA (1) | ZA200500768B (is) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010333829A1 (en) | 2009-12-23 | 2012-07-12 | Ironwood Pharmaceuticals, Inc. | CRTH2 modulators |
| WO2012009134A1 (en) | 2010-07-12 | 2012-01-19 | Ironwood Pharmaceuticals, Inc. | Crth2 modulators |
| US20130216552A1 (en) | 2010-07-12 | 2013-08-22 | Ironwood Pharmaceuticals, Inc. | Crth2 modulators |
| CN102276539B (zh) * | 2011-06-29 | 2013-08-14 | 赵雪梅 | 一种具有抑菌作用的化合物及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE640616A (is) * | 1962-12-19 | |||
| US3492397A (en) * | 1967-04-07 | 1970-01-27 | Warner Lambert Pharmaceutical | Sustained release dosage in the pellet form and process thereof |
| US4060598A (en) * | 1967-06-28 | 1977-11-29 | Boehringer Mannheim G.M.B.H. | Tablets coated with aqueous resin dispersions |
| US3538214A (en) * | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
| US4173626A (en) * | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
| YU41399A (sh) * | 1997-02-26 | 2001-09-28 | Pfizer Inc. | Derivati amida heteroaril-kapronske kiseline, njihovo dobijanje i njihova upotreba kao selektivnih inhibitora mip-1.alfa vezivanjem za njegov ccr1 receptor |
| PL342817A1 (en) * | 1998-02-05 | 2001-07-02 | Pfizer Prod Inc | Novel derivatives of dihydroxyhexanic acid |
-
2003
- 2003-07-31 MX MXPA05001781A patent/MXPA05001781A/es not_active Application Discontinuation
- 2003-07-31 EP EP03784383A patent/EP1539715A1/en not_active Withdrawn
- 2003-07-31 OA OA1200500028A patent/OA12894A/en unknown
- 2003-07-31 WO PCT/IB2003/003464 patent/WO2004014875A1/en not_active Application Discontinuation
- 2003-07-31 AU AU2003250450A patent/AU2003250450A1/en not_active Abandoned
- 2003-07-31 AP AP2005003226A patent/AP2005003226A0/xx unknown
- 2003-07-31 JP JP2004527195A patent/JP2005538130A/ja active Pending
- 2003-07-31 CA CA002494776A patent/CA2494776A1/en not_active Abandoned
- 2003-07-31 BR BR0313378-8A patent/BR0313378A/pt not_active Application Discontinuation
- 2003-08-05 UY UY27928A patent/UY27928A1/es not_active Application Discontinuation
- 2003-08-06 GT GT200300169A patent/GT200300169A/es unknown
- 2003-08-06 TW TW092121503A patent/TW200407316A/zh unknown
- 2003-08-08 US US10/637,475 patent/US20040072834A1/en not_active Abandoned
- 2003-08-08 AR AR20030102881A patent/AR040839A1/es unknown
- 2003-08-08 PE PE2003000794A patent/PE20040866A1/es not_active Application Discontinuation
- 2003-08-12 PA PA20038580401A patent/PA8580401A1/es unknown
-
2005
- 2005-01-26 ZA ZA200500768A patent/ZA200500768B/xx unknown
- 2005-01-27 IL IL16654805A patent/IL166548A0/xx unknown
- 2005-01-27 IS IS7674A patent/IS7674A/is unknown
- 2005-01-31 NO NO20050540A patent/NO20050540L/no unknown
- 2005-02-03 EC EC2005005588A patent/ECSP055588A/es unknown
- 2005-02-11 TN TNP2005000035A patent/TNSN05035A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05001781A (es) | 2005-04-25 |
| TNSN05035A1 (fr) | 2007-05-14 |
| AR040839A1 (es) | 2005-04-20 |
| WO2004014875A1 (en) | 2004-02-19 |
| BR0313378A (pt) | 2005-07-12 |
| AP2005003226A0 (en) | 2005-03-31 |
| OA12894A (en) | 2006-10-13 |
| ECSP055588A (es) | 2005-04-18 |
| AU2003250450A1 (en) | 2004-02-25 |
| UY27928A1 (es) | 2004-03-31 |
| TW200407316A (en) | 2004-05-16 |
| US20040072834A1 (en) | 2004-04-15 |
| IL166548A0 (en) | 2006-01-15 |
| NO20050540L (no) | 2005-03-10 |
| PE20040866A1 (es) | 2004-11-26 |
| IS7674A (is) | 2005-01-27 |
| EP1539715A1 (en) | 2005-06-15 |
| CA2494776A1 (en) | 2004-02-19 |
| PA8580401A1 (es) | 2004-02-16 |
| GT200300169A (es) | 2004-05-12 |
| JP2005538130A (ja) | 2005-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003241561A1 (en) | Pyrazolo-pyrimidine aniline compounds | |
| IL164597A0 (en) | Substituted 3-amino-thienoÄ2,3-bÜpyridine-2-carboxylic acid amide compounds and processes for preparing and their uses | |
| ZA200409989B (en) | Novel substituted sulfamate anticonvulsant derivatives. | |
| AU2003282548A1 (en) | Nano-chem-fet based biosensors | |
| HK1072772A1 (en) | Polymorph of acid 4-Ä2-Ä4-Ä1-(2-ethoxyethyl)-1H-benzimidazole-2-ilÜ-1-piperidinylÜethylÜ-alpha, alpha-dimethyl-benzeneacetic-4-Ä2-Ä4-Ä1-(2- | |
| AU2003283653A1 (en) | Solution search | |
| ZA200300208B (en) | Manufacture of high octane alkylate. | |
| AU2003256092A1 (en) | Anisotropic-electroconductive adhesive, circuit connection method and structure using the same | |
| HK1078087A1 (en) | Process for the preparation of (s,s)-cis-2-benzhydryl-3- benzylaminoquinuclidine | |
| AU2003247273A1 (en) | On demand real-time knowledge based connectivity | |
| ZA200304085B (en) | Set of elements for assembling structures. | |
| ZA200501624B (en) | Flat lamp, production method thereof and application of same. | |
| AU2003251779A1 (en) | Electrode connector with rivet | |
| AU2003227917A1 (en) | New recovery process | |
| ZA200500768B (en) | Crystal forms os quinoxaline-2-carboxylic acid Ä4-carbomoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-,ethyl-octylÜ-amide | |
| AU2003289910A1 (en) | Isophtalic acid derivatives | |
| AU2003212979A1 (en) | Substituted fused pyrazolecarboxylic acid arylamides and related compounds | |
| AU2003225474A1 (en) | Facilitating improved workflow | |
| ITMI20022704A1 (it) | Procedimento per la produzione di mesitilene e durene. | |
| AU2003276026A1 (en) | Bicalutamide forms | |
| DE60324703D1 (de) | Barbitursäure derivaten. | |
| IL163572A0 (en) | Method for manufacturing flat paneldisplay substrates orbotech ltd. | |
| AU2003255454A1 (en) | Heterocyclylcarbonyl aminocyclopropane carboxylic acid derivatives | |
| TWI318790B (en) | High-frequency substrate | |
| AU2003301750A1 (en) | Recovery process |